Search

Search Results
Results 931 - 940 of 1077 for Diabetes Type II
  • News - 15 Feb 2023
    In a recent study published in the journal Immunity, researchers reviewed the T cell response in cancer and autoimmunity to propose strategies for more effective immunotherapies.
  • Health - 23 Jan 2023
    There has been an exponential rise in the number of obese individuals especially in developed nations like United States and United Kingdom. Now obesity has become a public health problem in most...
  • Drug - 6 Jan 2023
    Consumer Medicine Information (CMI) about Perisyl Combi (perindopril erbumine and indapamide hemihydrate) intended for persons living in Australia.
  • Drug - 19 Dec 2022
    Consumer Medicine Information (CMI) about Adesan (candesartan cilexetil) intended for persons living in Australia.
  • Drug - 6 Dec 2022
    Consumer Medicine Information (CMI) about Entresto intended for persons living in Australia.
  • Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.
  • Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Drug - 15 Jul 2022
    Consumer Medicine Information (CMI) about Prexum (perindopril) intended for persons living in Australia.
  • News - 7 Apr 2022
    For world health day, we speak to Dr. Sam Myers, director of the Planetary Health Alliance, about the importance of raising awareness surrounding planetary health.
  • Health - 17 Jan 2022
    Asthma is a chronic condition characterized by lung airway inflammation that is caused by both genetic and environmental factors.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.